DUSA Announces Results for Phase IIB Trial Of Levulan® Photodynamic Therapy for Moderate to Severe Acne

About the Study
The 266-patient randomized, controlled, investigator blinded study was conducted at 14 clinical trial sites in the United States and was designed to detect a 20% difference in efficacy between the two major groups in the study with 90% statistical power. The study’s objective was to determine and compare the safety and efficacy of multiple broad area photodynamic therapy (PDT) treatments with Levulan(R) in combination with the BLU-U(R) brand light versus use of the BLU-U without Levulan in patients with moderate to severe facial acne vulgaris. Levulan in vehicle or the vehicle alone was applied to the full face of participants approximately 45 ± 15 minutes prior to treatment with 5 or 10 J/cm2 of light with the BLU-U. Patients received treatment once every three weeks with a maximum of four treatments. The primary efficacy assessment occurred three weeks after the last treatment. Primary efficacy assessment consisted of change in inflammatory lesion counts relative to patient baseline and Investigator Global Assessment (IGA) of acne severity with success defined as a two point or more improvement on the IGA scale three weeks after the final treatment. Safety endpoints consisted of the tolerability of treatment and local and systemic adverse events.

Study Results
The results did not demonstrate a statistically significant difference between the Levulan PDT and the control group. The study demonstrated a statistically significant reduction in the number of inflammatory lesions from baseline with the median reduction at three weeks after the final treatment of 37.5% (95% confidence limits of 48.4, and 30.3) for BLU-U (10J/cm2) plus vehicle containing Levulan and 41.7% (95% confidence limits of 56.7, and 29.0) for BLU-U (10J/cm2) plus vehicle without Levulan (p value less than .0001). These positive results persisted or were improved at the six week follow-up. All patients tolerated their treatments well. There were no severe adverse events reported and no patients terminated the light therapy treatment early. The more severe patients (n equals 139, Grade 4) demonstrated a median of about a 50% reduction in inflammatory lesions from baseline in both groups.

About the BLU-U(R)
DUSA’s patented BLU-U(R) Blue Light Photodynamic Therapy Illuminator offers effective, non-invasive and pain-free light treatment for moderate inflammatory acne. Narrow band blue light causes a photodynamic effect within the pilosebaceous gland that kills P. acnes, the bacteria primarily responsible for acne. BLU-U treatments can be a primary treatment, an alternative to pharmaceuticals and topicals, or an addition to skin care programs. In September 2003, DUSA received clearance from the U.S. Food and Drug Administration (FDA) to market the BLU-U without Levulan(R) PDT for the treatment of moderate inflammatory acne vulgaris and general dermatologic conditions.

About Levulan(R) Photodynamic Therapy (PDT)
Levulan PDT is a unique 2-step treatment currently indicated to treat Grade 1 or 2 actinic keratoses (AKs that have not yet become enlarged and thick) of the face or scalp. In the U.S., the therapy consists of treatment with Levulan(R) Kerastick(R) Topical Solution, 20% followed by illumination with DUSA’s BLU-U(R) brand light source.

About Acne
According to the American Academy of Dermatology, acne is the most common skin disorder in the U.S., affecting 40 to 50 million Americans. There are many types of acne, the most common of which is called acne vulgaris. Just beneath the surface of the skin lie hundreds of tiny glands called sebaceous glands. Their function is to collect and excrete the oily substance called sebum, to keep the skin healthy. However, the tiny pathway for the sebum to escape often becomes clogged and a bacterium called P. acnes grows inside. In a short time, the area swells up and forms a lesion on the skin. At certain times of life, this process becomes very active, troublesome and hard to control.

About DUSA Pharmaceuticals
DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan(R) photodynamic therapy (PDT) technology platform, and complementary dermatology products. Levulan PDT is currently approved for the treatment of Grade 1 or 2 actinic keratoses of the face or scalp. Dr. Shalita, quoted above, is a member of DUSA’s medical advisory board. DUSA’s other dermatology product is ClindaReach(R). DUSA is also researching additional indications for Levulan PDT, including oral leukoplakia in collaboration with National Institutes of Health (NIH) and the prevention of AK’s and SCC’s in immunosuppressed solid organ transplant recipients. DUSA is based in Wilmington, Massachusetts.

DUSA Pharmaceuticals
978.657.7500
www.dusapharma.com

Source: DUSA Pharmaceuticals

Injections not just for Crow’s Feet, but for Regular Feet Too!

Chicago based plastic surgeon discusses options for foot pain.

For many women walking can be a pain. The balls of their feet endure most of the impact of walking or running in most any type, style or heeled shoe. Well now there is a cure in sight! Board certified plastic and reconstructive surgeon Dr. Greg Wiener discusses the latest procedures that help get rid of foot pain without having to sacrifice shoe fashion.

Dr. Wiener suggests two different types of procedures to put an end to the pain occurring in the balls of the feet, the first being a foot-lift. The short procedure involves injecting a collagen enhancer into the ball of the foot to a patient undergoing the minutes-long procedure only feels the pinch for about two seconds, similar to what one might feel during a bee sting. Most patients feel the results immediately, and compare the feeling to walking on pillows.

The second option to relieve ball-of-foot pain is Botox injections. Using a micro-needle, minute amounts of Botulinum Toxin are injected into specific area of the body, in this case the balls of the feet. The Botox then relaxes those muscles and pads the balls of the feet, to give more cushion for more comfort when walking in higher heeled shoes.

Although both procedures are effective, Dr. Wiener suggested the collagen enhancer as opposed to the Botox injections. The collagen enhancer has a more long-term effect and adds more padding the bottom of the feet, as opposed to the Botox, which does pad the feet, but tightens the skin as well which may cause the discomfort of the foot to come back sooner.

About Dr. Greg Wiener
Dr. Greg Wiener M.D. FACS is a board certified cosmetic and reconstructive surgeon who has been practicing at Resurrection Hospital for the past 9 years. He was named a Consumer Reports “Top Surgeon” and completed his residency at the University of Illinois at Chicago. Dr. Wiener has been featured in several media outlets such as E! News Live, WFLD-TV, WMAQ-TV, Univision Online, Oxygen Magazine, Healthy and Fit Magazine, Forbes, US Weekly, Life & Style Weekly, Globe, Daily Herald, Chicago Sun Times and the Today Show Website.

Gregory Wiener, M.D., F.A.C.S.
773.763.3990
www.TheArtofPlasticSurgery.com

Source: Dr. Gregory Wiener

Relastin - New Multi-Tasking Product Solves the Anti-Aging Equation

Relastin Ultra Emollient hydrates, smoothes and firms while improving elasticity -

MOUNTAIN VIEW, Calif. – There are thousands of products and procedures on the market today that claim to turn back the hands of time. Traditionally these treatments focus on restoring collagen, but fail to address all of the factors that play into the anti-aging equation and contribute to the appearance of youthful skin.

Relastin, the skincare brand known for shifting the anti-aging focus to include elastin – the other essential protein in skin, has once again set a new standard in skincare. Ultra EmollientTM is the latest addition to the company’s cult favorite and award-winning line of products. This multitasking cream solves the anti-aging equation by addressing each cause of aging skin – elastin breakdown, loss of moisture and decreased collagen. Ultra EmollientTM’s groundbreaking formula combines Relastin’s signature Zinc Firming Complex™, the first ingredient proven to increase functional elastin content, with the vitamins, peptides and extracts necessary for total skin rejuvenation.

The first part of the equation is hydration. Loss of moisture is a very common problem for older skin, and parched skin makes lines and wrinkles more apparent. Ultra EmollientTM is a luxurious cream that comforts and soothes dry skin – leaving it soft, plump, and velvety smooth. In fact, recent clinical testing shows that 91% of users experienced increased moisture in the skin.

Ultra Emollient is enriched with a cocktail of cell penetrating vitamins and peptides to improve skin tone and texture. Vitamin C, a potent antioxidant, works to fight free radical damage, brighten the complexion and encourage collagen production. Vitamin A reduces the appearance of wrinkles and stimulates production of collagen. Peptides further minimize surface wrinkles and improve skin firmness.

Relastin’s patent-pending, functional elastin boosting Zinc Firming Complex™ completes the age defying equation and sets Ultra Emollient apart from the competition. Elastin is an essential protein in skin that gives it firmness, tone and elasticity. As we age the protein fibers created in our youth breakdown and weaken, causing the skin to lose firmness, sag and wrinkle. Relastin Ultra EmollientTM is proven to dramatically improve skin elasticity and firmness by boosting the production of functional elastin fibers. Clinical tests show that roughly 90% of users saw visibly reduced fine lines and wrinkles, while 81% experienced improved epidermal elasticity.

Relastin Ultra EmollientTM is more than just a moisturizer or a skin treatment; it is a complete anti-aging solution. This all-encompassing new product offers hydration, visibly reduced wrinkles, increased elasticity and firmness in as little as 2 weeks. The Relastin product line is available on the Relastin website, select online retailers and select dermatologist’s offices nationwide.

ABOUT RELASTIN
Relastin is the first and only clinically proven product to increase the production of elastin, a natural protein that gives the skin elasticity. Relastin penetrates the skin to work with the cells to promote the formation of elastin, which the body ceases producing at puberty.

Revance Therapeutics Inc.
800.808.2624
www.relastin.com

Source: Revance Therapeutics Inc.

CoolTouch Launches “CoolLipo Trio” Offering Physicians Three Functions in One

- New CoolLipo Trio allows physicians to do more in less time with minimal investment using trusted and effective CoolTouch technology for laser-assisted lipolysis and skin tightening, non-ablative skin rejuvenation and endovenous ablation -

ROSEVILLE, Calif. – Debuting from CoolTouch Inc., a leading U.S.-based developer and manufacturer of innovative, advanced laser products for medical professionals, the CoolLipo Trio™ answers the need for increased practice profitability and patient care for a minimal, one-time investment. The multi-purpose CoolLipo Trio allows physicians to perform laser-assisted lipolysis and skin tightening with CoolLipo™, endovenous ablation with CTEV™ and non-ablative skin rejuvenation with CoolBreeze™, all in one laser system. This new combination system helps physicians expand their practices and services without the need to purchase multiple instruments and equipment, while increasing the scope of patient care and improving the overall success of physicians’ practices.

The CoolLipo Trio system is based on CoolTouch’s signature 1320 nm wavelength, a wavelength that has a proven track record for fat ablation, dermal collagen regeneration and endovenous ablation of varicose veins. This particular wavelength targets water within the cellular structure and has a shallow depth of penetration, limiting the potential for collateral damage to outlying structures.

The CoolLipo Trio’s first and foremost modality is the CoolLipo procedure for laser-assisted lipolysis and skin tightening, which is used widely to sculpt small areas of the body such as the neck, jowls, chin, and saddlebags, or to tighten a loose belly. CoolLipo can be used in conjunction with larger liposuction cases by using the CoolBlue Duet™, the only handpiece on the market that lases and aspirates simultaneously, reducing procedure time and providing tighter skin more efficiently.

In addition to laser-assisted lipolysis and skin tightening, the CoolLipo Trio also includes an endovenous ablation modality with CoolTouch CTEV, allowing physicians to treat patient’s varicose veins. The CTEV procedure provides patients with an attractive alternative to vein stripping and is cited as having a greater than 95% closure of varicose veins after just one treatment. Physicians have reported that the endovenous procedure provides less discomfort, a quicker recovery period and better clinical and cosmetic outcomes at a lower cost than other available treatments.

CoolBreeze, the third modality included in the CoolTouch Trio system, allows physicians to perform non-ablative skin rejuvenation treatments. The CoolBreeze treatment penetrates dermal tissue to stimulate the generation of collagen without surface damage, and is a comfortable, safe procedure that can be performed in a series of treatments for fine lines, skin tightening, acne, and acne scarring.

The CoolLipo Trio’s unique features include the highest peak power range on the market, with a range of 2 – 25 watts in 0.5 increments, allowing physicians to perform a wide range of procedures using select parameters. Variable pulse lengths produce different effects, such as acoustic destruction for fat ablation or more gradual heating for skin tightening. Additionally, the Ablate/Thermal button allows physicians to easily switch back and forth between fat ablation and thermal heating during a laser lipolysis procedure, saving time and increasing treatment efficiency.

Other signature CoolTouch features include: JouleTracker™, an automatic pullback device on the endovenous platform, equipped with three speeds for efficacy and an alert feature if the fiber slips; an exclusive fiber test port, ensuring delivery of the proper level of laser energy through the fiber for reliability and excellent patient outcomes; and the largest range of sizes and types of handpieces and cannulas, as well as fibers. The CoolLipo Trio’s easy-to-use control interface makes training and immediate incorporation into existing practices simple and quick. The large number and variety of treatment indications and unique system specifications are unmatched in the marketplace.

Backed by CoolTouch’s clinical research and science-based technology, as well as a reputation for reliability and consistent operation, the CoolLipo Trio offers physicians three functions – laser-assisted lipolysis with skin tightening, non-ablative skin rejuvenation and endovenous ablation – in one system to increase patient care and practice profitability.

About CoolTouch Inc.
CoolTouch Inc. is a leading U.S.-based developer and manufacturer of innovative, advanced laser products for medical professionals. Engineering and science-based, CoolTouch is considered a pioneer in the medical and aesthetics technology industry. In 1994, CoolTouch introduced the first 1320 nm wavelength laser to medical professionals for non-ablative wrinkle treatment. CoolTouch continued to set new standards in the industry with the launch of CoolTouch lipolysisin 2004 for varicose vein treatment and with CoolLipo arefor CTEV skin and laser tightening in 2007. CoolTouch products are FDA-cleared and manufactured in Roseville, Calif.

CoolTouch Inc.
877.858.COOL (877.858.2665)
www.CoolTouch.com‎

Source: CoolTouch Inc.

Palomar Wins Candela’s Texas Lawsuit

Palomar Medical Technologies Inc (Nasdaq: PMTI) today announced that, following trial, a jury has found that Palomar’s products do not infringe a Candela patent, specifically U.S. Patent No. 5,810,801 (the “‘801 Patent”). The trial took place in United States District Court for the Eastern District of Texas. Palomar’s Lux1540, Lux1540z, LuxIR and LuxDeepIR handpieces when used on the StarLux 500 and 300 Systems were found non-infringing. In addition, the jury found that all of the claims at issue in ‘801 Patent were invalid over prior art.

Candela accused eight Palomar handpieces when used with four different platform systems of infringing all of the claims of three Candela Patents. Specifically Candela accused Palomar’s LuxY, LuxYs, LuxG, LuxB, Lux1540, Lux1540z, LuxIR and LuxDeepIR handpieces when used on the StarLux 500, StarLux 300, MediLux or EsteLux Systems of infringing U.S. Patent Nos. 5,810,801; 6,120,497 and 6,659,999. On June 20, 2008, Candela dropped its accusations against Palomar’s LuxB handpiece. Then on September 22, 2008, just days before the start of trial, Candela (i) dropped its accusations against Palomar’s LuxY, LuxYs, and LuxG handpieces, (ii) dropped two of its patents from the lawsuit, specifically 6,120,497 and 6,659,999, and (iii) dropped from the lawsuit all method claims in 5,810,801. Consequently, Candela went to trial on September 29th accusing only Palomar’s Lux1540, Lux1540z, LuxIR and LuxDeepIR when used with the StarLux 500 or 300 of infringement of only claims 11-14 of 5,810,801. In addition, Candela significantly reduced the amount of damages it was seeking.

Chief Executive Officer Joseph P. Caruso commented, “We are very pleased with the jury’s decision. The jury’s verdict completes our win in this lawsuit by finding our products to be non-infringing and the patent claims at issue to be invalid. We are also happy that the costs associated with this trial are behind us.”

Mr. Caruso continued, “Importantly, we now move closer to Palomar’s lawsuit against Candela for infringement of Palomar’s hair removal patents: U.S. Patent Nos. 5,595,568 and 5,735,844. Candela has admitted that it brought the lawsuit in Texas in retaliation for the hair removal lawsuit. In this just completed Texas trial, Candela’s corporate representative testified under oath that the demand for hair removal was far greater than the demand for any other laser treatment. We agree. That trial is not yet scheduled but we expect the trial to take place next year.”

About Palomar Medical Technologies, Inc.
Palomar is a leading researcher and developer of light-based systems for cosmetic treatments. Palomar pioneered the optical hair removal field, when, in 1997, it introduced the first high-powered laser hair removal system. Since then, many of the major advances in light-based hair removal have been based on Palomar technology. In December 2006, Palomar became the first company to receive a 510(k) over-the-counter (OTC) clearance from the United States Food and Drug Administration (FDA) for a new, patented, home use, light-based hair removal device. OTC clearance allows the product to be marketed and sold directly to consumers without a prescription. There are now millions of light-based cosmetic procedures performed around the world every year in physician offices, clinics, spas and salons. Palomar is testing many new and exciting applications to further advance the hair removal market and other cosmetic applications. Palomar is focused on developing proprietary light-based technology for introduction to the mass markets. Palomar has granted The Procter & Gamble Company a non-exclusive License Agreement to certain patents, technology and FDA documents related to the home-use, light-based hair removal field for women. In addition, Palomar has an exclusive development and license agreement with Johnson & Johnson Consumer Companies to develop and potentially commercialize home-use, light-based devices for reducing or reshaping body fat including cellulite, reducing the appearance of skin aging, and reducing or preventing acne.

Palomar Medical Technologies, Inc.
781.993.2411
www.palomarmedical.com

SOURCE: Palomar Medical Technologies, Inc.

Photo Therapeutics Expands Its Presence in the Consumer Market with Launch of Omnilux New-U in CVS/pharmacy this Fall

CARLSBAD, Calif. (September 26, 2008) — Photo Therapeutics (PTL), a leader in the development of proprietary therapeutic LED technology for the physician dermatology market, announced today with PhotoMedex that CVS/pharmacy is launching PTL’s proprietary Omnilux™ LED-based technology at nearly 600 Healthy Skincare locations this fall and cvs.com.

CVS/pharmacy to carry the Omnilux New-U™
CVS/pharmacy will distribute Photo Therapeutics’ clinically-proven hand-held LED device for skin rejuvenation and the reduction of fine lines and peri-orbital wrinkles beginning October 2008 in their Healthy Skincare Center locations. The Omnilux New-U™ is the first and only hand-held device to receive clearance from the U.S. Food and Drug Administration for over-the-counter sales to consumers for use at home.
Ms. D’Arcy, the chief executive officer of Photo Therapeutics, stated, “We are excited to be working with a respected retailer like CVS/pharmacy to bring our LED light therapy technology to consumers across the country. The New-U is effective, affordable and simple to use. It is a product whose time has come.”

CVS/pharmacy will market the New-U through its Healthy Skincare Centers, found in nearly 600 stores throughout the United States. The New-U can be used in combination with a skincare regime or as a stand-alone treatment. The home device light technology market is viewed as an important emerging market.

Photo Therapeutics has announced its intent to be acquired by PhotoMedex, Inc. (NASDAQ: PHMD), leaders in medical laser treatments for psoriasis and other skin diseases and marketers of skincare products to dermatologists. This union is expected to spur further investment in the research, development and marketing of Photo Therapeutics’ LED and light-based therapies under PhotoMedex to complement therapies in the medical, beauty and cosmetic fields. Ms. D’Arcy stated: “It makes perfect sense to team up with PhotoMedex. Working together, we can answer the demand in this emerging market.”

About the Proposed Photo Therapeutics Acquisition
On August 4, 2008 Photo Therapeutics and PhotoMedex signed a definitive agreement for PhotoMedex to acquire Photo Therapeutics. The proposed acquisition is expected to close in the fourth quarter of 2008 and is expected to be funded through an investment of convertible debt provided by a third-party investment fund. PhotoMedex will seek approval from its stockholders for the investment; the shareholders of Photo Therapeutics have already ratified the definitive agreement and the terms proposed for financing the acquisition.

About Photo Therapeutics
Photo Therapeutics is a developer and provider of non-laser light devices and associated skin care products for the treatment of a range of clinical and aesthetic dermatological conditions. The company operates out of three primary business segments: Professional Devices, Home Use Devices and Skin Care Consumables. The company has a large professional installed base in physician offices, spas and salons. Photo Therapeutics’ Omnilux and Lumiere product platforms have generated significant brand equity among professionals and end users given their proven efficacy, ease of use and noninvasive, pain-free regimes. The company’s systems treat a wide range of dermatological conditions including acne, photodamage, skin rejuvenation, psoriasis, post-surgery wound healing and non-melanoma skin cancer.

LED technology is based on photo biomodulation and dynamics rather than photo-thermolysis. Photo Therapeutics has recently developed the Omnilux Clear-U and Omnilux New-U, two OTC consumer products addressing the acne and skin rejuvenation markets. The company’s home-use products are designed to deliver the same clinical results as their well established professional products. To augment the effects of the Omnilux OTC product line, Photo Therapeutics provides a diverse line of photoceuticals, which generate incremental recurring revenue per end user. Photo Therapeutics’ LED technology is protected by 18 patents and 20 applications, which the company believes will restrict other parties from developing similar products.

About PhotoMedex
PhotoMedex offers a wide range of products and services across multiple specialty areas, including dermatology, urology, gynecology, orthopedics and other surgical specialties. PhotoMedex is a leader in the development, manufacturing and marketing of medical laser products and services. PhotoMedex also develops and markets products based on its patented, clinically proven Copper Peptide technology for skin health, hair care and wound care. PhotoMedex sells directly to dermatologists, plastic and cosmetic surgeons, spas and salons and through licenses with strategic partners into the consumer market, including a long-term worldwide license agreement with Neutrogena(R), a Johnson & Johnson company. ProCyte brands include Neova(R), Ti-Silc(R), VitalCopper(R), Simple Solutions(R) and AquaSante(R).

Photo Therapeutics, Inc.
760.607.0488
www.phototherapeutics.com

Source: PhotoTherapeutics

New Products and Industry Advancements Debut at NYC Medical Aesthetics Expo

Product innovations and new technologies are key features of 2008 New York Spa & Resort Expo and Conference and Medical Aesthetics Conference and Expo

NEW YORK – Hundreds of cutting-edge products and advancements will debut at the 2008 New York Spa & Resort Expo and Conference and Medical Aesthetics Conference and Expo, coming soon to the Jacob Javits Center in New York City. From September 20-22, 2008, dedicated industry leaders will bring the newest trends, products, services, and treatments to thousands of spa and medical aesthetics professionals, who are searching for the latest innovations to offer their clients and patients.

As leading events for the latest advancements in the spa and medical aesthetics industries, the Spa & Resort Expo and Conference and Medical Aesthetics Conference and Expo will offer attendees the opportunity to preview what is new throughout many areas of the show floor. This includes the New Product Showcase, sponsored by SpaFinder, a 360-degree media company dedicated to the global spa marketplace, which will be specifically dedicated to the newest product launches. Also, launching this year in New York, the Edge Pavilion will provide a platform for first time exhibitors to showcase their special products and services. The new GreenSpa Expo, sponsored by Organic Spa magazine, is a dedicated area for spas and medical spas to display their green, natural and organic spa products and services.

“This year’s New York event will be filled with innovations in the quickly advancing and ever-evolving spa and medical aesthetics industries,” said event vice president Nancy Largay. “Specifically, the GreenSpa Expo will show some of this year’s biggest trends, includingorganic, natural and green products. It will be a great resource for buyers interested in these fast-growing trends.”

New products will be launching in categories that include anti-aging skincare, cosmeceuticals, exotic ingredients, massage and spa tools, medical spa business tools, medical technology, multi-taskers, natural foods, non-invasive options, spa wear, and much more.

Here’s a sampling of a few not-to-be-missed new products:

ANTI-AGING SKINCARE
- Mesoéclat Skin Rejuvenation Treatment, Booth 510: This new treatment was developed to provide the best possible defense against the signs of aging by strengthening skin’s structure. The active ingredients are designed to enhance brightness of complexion, soften lines and encourage firmer, younger looking skin.
www.mesoesteticusa.com
- T’Fivve, Booth 836: This age-defying anti-wrinkle regimen is ideal for all skin types. There are no side effects, including dryness, irritation, hyperplasia, or skin damage, even on the most sensitive skin. With patented, clinically proven ingredients, 72 percent of users have seen effects in just 8 weeks.
www.skinfica.com
- TNS Essential Serum, Booth 433: This unparalleled serum provides TNS Recovery Complex® in one chamber and a potent mixture of anti-aging ingredients in the other chamber to synergistically transform and regenerate skin. www.skinmedica.com

COSMECEUTICALS
- C.E. Polypeptides Treatment, Booth 323: The Medicalia C.E. Polypeptides Treatment combats the signs of again, wrinkles and slackening of the skin. It will also smooth fine lines and improve the overall appearance of skin. With advanced freeze-dried technology; the treatment is an extremely hydrating and intensive professional anti-aging treatment. www.medicalia.com
- MD Corrective Care, Booth 319: MD Corrective Care’s new hydroquinone-free brightening system gets skin looking healthy with their three-step method: first PEEL with AHAs & Papaya extracts, then SEAL and treat with second skin technology using the latest generation of brighteners, and finally REVEAL unified radiance. www.mdcorrectivecare.com
- Phloretin CFTM, Booth 317: After five years of extensive research, SkinCeuticals has developed this patent-pending breakthrough treatment that combines the newly-discovered, broad-range power of phloretin with vitamin C and ferulic acid to conquer sources of damage at every level. www.skinceuticals.com
- PSORENT Psoriasis Topical Solution, Booth 441: PSORENT Psoriasis Topical Solution is clinically-proven and specially formulated to help relieve the symptoms of psoriasis. This steroid-free formulation is fast-drying and applies easily with a no-mess applicator. www.neostrata.com

EXOTIC INGREDIENTS
- Blu Buff Microdermabrasion Paste, Booth 247: A uniquely formulated cream-based paste with exfoliating Jojoba ester beads, it dramatically buffs away dead skin cells, leaving skin soft and glowing. www.vivantpharmaceuticals.com
- Restorative Red Marine Algae Cream, Booth G11: Susan Ciminelli Day Spa’s new cream made from red marine algae fights free radicals to reduce fine surface lines and improve the firmness of skin. Many patients exhibit a 20% increase in collagen stimulation and a 70% increase in moisture retention. www.susanciminelli.com
- Sea Gems, Booth 352: Rhonda Allison Clinical Enterprises’ Sea Gems nourishes the skin, reduces wrinkle formation and delivers oxygen to the skin tissue for healthier, more vibrant skin. www.rhondaallison.com

MASSAGE AND SPA TOOLS
- Pristine: the Precision Diamond Peel System, Booth 315: This state-of-the-art microdermabrasion system enables the most advanced, full-body exfoliation services. Clients can see and feel results immediately. www.vioramed.com
- WELLSYSTEM Dry Water Massage Bed, Booth 360: This comfortable Dry Water Massage Bed, which comes in MEDICAL and RELAX versions, adds to any massage and will keep spa clients coming back for more. www.kellehermedical.com

MEDICAL SPA BUSINESS TOOLS
- LocateADoc.com, Booth 209: Partnering with Everyday Health, Google, Yahoo!, MSN, and AOL, Mojo Interactive’s LocateADoc.com offers physicians innovative ways to promote their practice online, obtain new patients and maximize their exposure via the Web. www.locateamedispa.com, www.locateadoc.com
- Profect PhotoProTM, Booth 321: ProfectTM Medical Technologies innovative new PhotoProTM allows for easy standardization and analyzing of clinical photographs with digital imaging software. www.profectmedical.com

MEDICAL TECHNOLOGY
- Canfield Imaging Systems, Booth 301: The REVEAL Imager from Canfield Imaging Systems, makers of the VISIA, is a new portable machine that uses Canfield’s signature RBX technology to view any existing sun damage and skin discoloration below the surface. The facial imaging device detects patients’ sun damage, wrinkles, crow’s feet, and pore size. www.canfieldsci.com
- C-Sculpt Cellulite System, Booth 241: C-Sculpt Cellulite System is DermaMed International’s newest treatment for cellulite. Its triple action system uses LED, cooling and massage to eliminate cellulite as well as improve skin’s smoothness, tone and elasticity. www.dermamedint1.com
- Isolaz, Booth 553: Isolaz™ is a painless device-based treatment powered by breakthrough technology called photopneumatics, which combines vacuum with broadband light to treat all four types of acne, skin rejuvenation and hair removal. This deep pore laser therapy can completely purify your skin. www.aesthera.com
- MesoDerm, Booth 520: AA Advanced Technology, Inc.’s MesoDerm is the only FDA Approved Class III drug delivery system. The patented procedure allows for any drug, or combination of rejuvenating substances, to be delivered into the tissue with the effectiveness of injection, but without the pain of a needle. www.mesoderm.com
- SilkPeelTM, Booth 313: SilkPeel™ uses many different treatment serums to address a large variety of skin conditions. It infuses these products deep into the skin - where they are most effective - instead of just sitting on top of skin, like a lotion or cream might. The patented SilkPeel™ hand piece deeply delivers vitamins, antioxidants and other therapeutic ingredients that skin needs most for maximum effectiveness. www.silkpeel.com
- SmartXide DOT Therapy – Fractional CO2 Laser System, Booth 210: Dermal Optical Thermolysis, or DOT Therapy, uses the SmartXide DOT CO2 laser system to provide a revolutionary way to reverse the aging process by eliminating wrinkles, acne, and sun damage. With only one treatment and minimal downtime, patients can take years off their skin. www.eclipsemed.com

MULTI-TASKERS
- 12 In 1 Beauty Instrument, Booth 631: This versatile piece of equipment has everything a spa professional could ever need all in one, including a vacuum, a spray, brush, and even a towel cabinet.
www.bns-beautysupply.com
- Bethesda Sunscreen Soap, Booth G2: Bethesda Sunscreen Soap contains a combination of healing and therapeutic properties. It not only moisturizes skin, but it also protects the body from the harmful rays of the sun by leaving behind an unnoticeable protective layer that provides daily sun protection. This will keep skin looking young and fresh. www.bethesdaskincare.com

NATURAL FOODS
- Dynamise Infusion, Booth G18: Dynamise Infusion is a beneficial and refreshing “beverage of the future” that is high in antioxidants and made with premium quality organic ingredients. It has a unique aromatic taste and zero calories. www.dynamise.ca
- M’lis Instant Meal, Booth 915: M’lis Instant meal is a 177-calorie, sugar-free nutrition drink that mixes easily with water or milk. It is available in orange cream, chocolate or vanilla. www.mlis.com

NON-INVASIVE OPTIONS
- The CryoProbe, Booth 435: The CryoProbe is a unique hand held cryosurgical instrument that delivers unparalleled freezing power directly to skin lesions with precision, thereby not affecting surrounding tissue.
www.cryo-surgical.com
- ALEX COSMETICA USA, Booth 611: This all-natural peeling method renews and regenerates skin in just five days. Not only does it improve skin’s texture and tone, it also reduces fine lines and wrinkles, and restores skin’s natural glow. www.alexcosmeticusa.com
- AdorAge MD, Booth 536: AdorAge MD is a powerful anti-aging solution that is an alternative to injections or surgery, which means less pain, money and wasted time. www.adoragemd.com
- It Works, Booth 638: This all-natural, herbal body applicator quickly melts fat away. It works by breaking down fat and toxins in the fat cells, instead of just getting rid of water weight. The cream can be applied to any area to tone, tighten, firm and lose fat. www.itworks.net

SPA WEAR
- Revolutionary Fabric, Booth 351: SunSoul’s revolutionary fabric is the first of its kind to deliver healthy light from the sun while blocking out the harmful UV rays. www.sunsoul.com
- World’s Softest, Booth 623: It is almost like walking on clouds when wearing World’s Softest’s luxurious socks, wraps, robes, and footsies. They are the perfect compliment to any spa treatment. World’s Softest is also launching new products at their booth. www.worldssoftest.com

Hundreds of product innovations, technological advancements and access to the newest developments in service and treatments make the Spa & Resort & Resort Expo and Conference and Medical Aesthetics Conference and Expo the ultimate resources for cutting-edge industry information.

About Reed Exhibitions
Reed Exhibitions is the world’s leading events organizer. In 2006, Reed brought together over six million industry professionals from around the world generating billions of dollars in business. Today, Reed events are held in 34 countries throughout the Americas, Europe, the Middle East and Asia Pacific, and are organized by 37 fully staffed offices.

Reed organizes a wide range of events, including exhibitions, conferences, congresses and meetings. Its portfolio of over 460 events serves 52 industry sectors, including: Aerospace and defense, building and construction, design, electronics, energy, oil and gas, entertainment, food and hospitality, gifts, healthcare, IT/telecoms, jeweler, manufacturing, marketing and business services, pharmaceuticals, property, publishing, security, sport and recreation, transport and logistics, travel.

Working closely with professional bodies, trade associations and government departments Reed ensures that each and every event is targeted and relevant to industry needs. As a result, many Reed events are market leaders in their field.

Reed Exhibitions is part of Reed Elsevier Group plc, a FTSE-100 company and world-leading publisher and information provider.

Reed Exhibitions
877.271.6789
www.spaandresortexpony.com

Source: Reed Exhibitions

SkinMedica Launches New TNS Essential Serum™
Combines TNS Recovery Complex® and APS Corrective Complex™

New York, NY – September 4, 2008 – SkinMedica, Inc. launches a revolutionary dual chamber, anti-aging serum, TNS Essential Serum™, the first product to combine TNS Recovery Complex® and new APS Corrective Complex™.

TNS Essential Serum™ features the renowned growth factor serum, TNS Recovery Complex® in one chamber, combined with APS Corrective Complex™ — a potent mixture of three novel peptides and seven antioxidants including new Ergothioneine (EGT), a natural amino acid with super-antioxidant properties that protect cells against free radicals – in the other chamber. The two formulas work in synergy to transform and regenerate skin for a youthful, glowing appearance.

CLINICAL STUDY
In a recent clinical study, 37 women age 32-55 with mild to severe wrinkles used TNS Essential Serum twice-daily for three months. 89% of all subjects saw a vast improvement in overall skin tone and texture with all subjects showing statistically significant improvements in the following evaluation points:

• Improvement in fine and coarse wrinkles
• Improvement in skin radiance and elasticity
• Protection from UV exposure and subsequent skin damage
• Excellent patient satisfaction
• Well tolerated with no treatment-related adverse events

TNS Essential Serum™ launches in September 2008 and is available nationwide at doctor’s offices and medically supervised spas. Visit Skinmedica.com for locations.

SkinMedica, Inc. is an aesthetic and pharmaceutical company focused on developing, acquiring and commercializing products that improve the appearance of skin and treat dermatologic conditions and diseases.

SkinMedica
877.944.1412
www.tnsrecoverycomplex.com

Source: SkinMedica

L.W. Gatz Announces a New Breast Sizing System for Women Considering Breast Augmentation Surgery

Woodbury, MN. September 2, 2008: Deciding on a breast implant size can be a challenging and emotional decision for many women considering breast augmentation. Selecting the incorrect implant size is one of the most common reasons women undergo subsequent surgeries. L.W. Gatz has created the Purlz™ Breast Sizing System to help patients choose right the first time.

Breast Sizing Purlz™ are tester implants designed to simulate the effect of various implant sizes on a woman’s body. Until now, women have often used plastic bags filled with rice or water to experiment at home with breast implant sizes. Unlike other commercially available systems, the Purlz™ Breast Sizing System is designed to be discretely worn under most clothing.

Purlz™ are comfortable, lightweight, and durable, and can be worn for an extended period of time. They are made of a microfiber spandex blend fabric filled with 100% polyethylene plastic beads comparable to the volume of breast implants. The patent-pending system uses a uniquely constructed hook and strap method designed to securely attach the tester implant to a bra without the use of a pocket. The system packages include the patient’s choice of one, two, or three Purlz™ sets and a
sports bra.

Researchers at L.W. Gatz have found that the breast implant size decision goes beyond simple appearance. The emotional and psychological effects of breast augmentation are important to experience in addition to the physical appearance. Trying various sizes during everyday activities can help a woman acclimate to her new proportions while getting valuable feedback from family and friends. The experience of living with different implant sizes can help a woman make an informed breast implant sizing choice.

L.W. Gatz
800.596.PURLZ (596-7875)
www.LwGatz.com

Source: L.W. Gatz

The Latest Innovation in Minimal Incision Brow Lift Surgery: BioGlue® Surgical Adhesive

(New York, NY) The first areas to show signs of aging are the regions around the eyes and forehead. Drooping of the skin on the brows and of the eyebrows themselves can be due to loose skin and fat loss around the brow, forehead and temples. Age, sun damage, and furrowing of the brow can also create wrinkles. A common procedure, the brow lift, also called a forehead lift, can improve all these problems and produce a younger, more refreshed look.

Until now, the gold standard in lifting the brow and forehead in brow lift surgery has been by utilizing sutures or Endotines. Now with the introduction of BioGlue® Surgical Adhesive, surgeons can perform a less invasive brow lift with a faster, more comfortable recovery time.

Joseph Eviatar, MD, board certified Ophthalmologist and Oculoplastic Surgeon at Chelsea Eye and Cosmetic Surgery Associates in New York City, is one of the investigators for BioGlue® and is involved in an FDA clinical trial. According to Eviatar, “So far, BioGlue® has been approved for use in cardiac and vascular reconstructive surgery. We are working to get approval for use of BioGlue® in cosmetic procedures such as endoscopic brow lifts where it has really proved to make a difference.”

BioGlue® is a two-component adhesive that creates a flexible, mechanical seal, independent of the body’s clotting mechanism, within 20 to 30 seconds, and reaches its maximum bonding strength in two to three minutes. Dr. Eviatar utilizes the BioGlue® to fixate the brow when performing endoscopic and transblepharoplasty brow lifts. Fewer incisions or “holes” are made when using this surgical adhesive as sutures, Endotines and screws are not needed. “There is no foreign device left in the body and BioGlue® gets absorbed by the body within a few months,” adds Eviatar.

CryoLife, Inc.
800.438.8285
www.cryolife.com

Source: CryoLife